Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Nutrients|December 17, 2024
Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in MiceLucas Rannier Ribeiro Antonino Carvalho, Maria Tydén, Miho Shimari, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal ProtectionWilliam Herrington, Jonathan Emberson, Natalie Staplin, et al.
Transplantation|January 25, 2005
Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trialBengt Fellström, Hallvard Holdaas, Alan G Jardine, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 2005
Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) StudyAlan G Jardine, Bengt Fellström, John O Logan, et al.
Theranostics|August 6, 2020
Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acidsDavid de Gonzalo-Calvo, Pablo Martínez-Camblor, Christian Bär, et al.
Free Radical Research|September 27, 2016
Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysisSandra Wagner, Mugurel Apetrii, Ziad A Massy, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 25, 2021
Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trialMadonna Salib, Sophie Girerd, Nicolas Girerd, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT StudyAlan G Jardine, Hallvard Holdaas, Bengt Fellström, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.
The Lancet. Diabetes & Endocrinology|August 2, 2016
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials, William Herrington, Jonathan Emberson, et al.
Pageof 9